Every winter, the queue outside a chest physician's clinic gets longer. Smog settles over north Indian cities after Diwali. Children come home from school coughing. Older patients with asthma or chronic bronchitis find their breathing worse with every cold morning. Then spring brings pollen, and the monsoon brings damp homes and viral infections. Respiratory complaints never really go away; they just change shape with the seasons.
For a distributor, that pattern is the foundation of a dependable business. A respiratory PCD pharma franchise covers products that are prescribed by almost every doctor — cough syrups, anti-allergy medicines, mucolytics, bronchodilators, nasal sprays and paediatric suspensions — with a strong base of chronic patients who need treatment month after month. This guide explains how the category works, what a sensible range looks like, who you will sell to, the rules you need to respect, and how to build a franchise that stays busy across the year.
The respiratory market in plain terms
Respiratory products serve two very different kinds of patients, and understanding the difference helps you plan.
Acute patients
These are people with a cold, a cough, a sore throat, a chest infection or a flare of allergy. They need treatment for a week or two. Demand from this group rises and falls sharply with the seasons, outbreaks of viral fever and air pollution. Cough syrups, antihistamines, decongestants, mucolytics and antibiotic suspensions serve this group.
Chronic patients
Patients with asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis and chronic bronchitis need medicines for months or years. They use controller inhalers, bronchodilators, montelukast combinations and nasal sprays regularly. This group provides a steady base of repeat prescriptions that does not disappear when the season changes.
A good respiratory franchise serves both. The acute products bring quick volume in the peak months; the chronic products keep the business stable the rest of the year.
What a respiratory range usually includes
Anti-allergy and anti-asthma tablets
Montelukast with levocetirizine is one of the most prescribed combinations in India for allergic rhinitis and allergy-related cough. Montelukast with fexofenadine, plain levocetirizine, fexofenadine and bilastine are also common. Doxofylline and theophylline-based products are used in some asthma and COPD patients.
Cough syrups
Dry cough syrups and wet (productive) cough syrups in several compositions. Expectorants and mucolytics such as ambroxol, guaifenesin and bromhexine, often in combination with a bronchodilator, are used for wet cough. Antitussives such as dextromethorphan are used for dry cough. Combination products should always be checked against the current list of permitted fixed-dose combinations, because a number of cough combinations have been prohibited over the years.
Mucolytics
Acebrophylline, N-acetylcysteine and ambroxol tablets, capsules and sachets for thick mucus in chronic bronchitis and chest infections.
Bronchodilators and inhalation products
Salbutamol, levosalbutamol, formoterol, tiotropium and budesonide in various forms: tablets, syrups, respules for nebulisers and inhalers. Inhalers and respules usually come from specialised manufacturers, so check whether your company has reliable sourcing for these.
Nasal sprays and drops
Saline nasal drops and sprays, decongestant nasal drops, and steroid nasal sprays such as fluticasone and mometasone for allergic rhinitis.
Paediatric syrups and suspensions
Children make up a large share of respiratory prescriptions. Antihistamine syrups, montelukast granules or chewables, paracetamol suspensions, cough syrups suitable for children, and antibiotic dry syrups and suspensions (such as amoxicillin with clavulanic acid, azithromycin and cefixime) are prescribed every day by paediatricians.
Throat products
Lozenges, gargles and throat sprays round out the range, especially for ENT specialists and general physicians.
A focused respiratory list of 30 to 45 products is usually enough to cover most prescriptions in a typical district.
Choosing your first twenty products
It is tempting to order every respiratory product a company offers. A tighter first list is safer. For a typical mixed territory, a sensible opening selection might be:
- Montelukast with levocetirizine tablets
- Montelukast with fexofenadine tablets
- Levocetirizine tablets and syrup
- Fexofenadine tablets
- Acebrophylline capsules
- Ambroxol-based wet cough syrup
- Dry cough syrup in a permitted composition
- Paediatric cough syrup suitable for children
- Paediatric antihistamine syrup
- Paracetamol suspension
- Amoxicillin with clavulanic acid dry syrup
- Azithromycin suspension
- Cefixime dry syrup
- Saline nasal drops for children
- Steroid nasal spray
- Decongestant nasal drops
- Levosalbutamol syrup or tablets
- N-acetylcysteine sachets or tablets
- Throat lozenges
- One nebulisation respule, if your company sources them reliably
This list covers most everyday prescriptions from general physicians, paediatricians and ENT specialists. Add specialist products for chest physicians once you have their attention.
Who prescribes respiratory products
Chest physicians and pulmonologists
They treat asthma, COPD and serious chest infections and prescribe controller medicines, bronchodilators, mucolytics and inhalation therapy. Chronic patients make their prescriptions very valuable over time.
Paediatricians
Children's coughs, colds, allergies and chest infections generate a huge number of prescriptions for syrups, suspensions, nasal drops and nebulisation products.
General physicians
The largest group by number. They handle most coughs, colds and allergies, especially in smaller towns. A short, reliable list of cough syrups, antihistamines and antibiotics serves them well.
ENT specialists
Allergic rhinitis, sinusitis and throat infections bring prescriptions for nasal sprays, antihistamines, montelukast combinations and lozenges.
Chemists
Many cough and cold products are bought over the counter. Chemist recommendations matter, especially for syrups and lozenges.
The chronic patient: why asthma and COPD matter
Acute coughs bring quick sales, but chronic patients bring stability. A patient with asthma may use a controller inhaler and a montelukast combination every day for years. A COPD patient may need bronchodilators, mucolytics and occasional antibiotics for the rest of their life. These patients return to the same doctor and usually stay with the same brands as long as they work.
Winning a chronic patient's prescription takes time. Chest physicians are careful about changing a stable patient's medicines, and rightly so. Your approach should be patient: introduce your products for new patients first, provide reliable information, and let the doctor decide when to use them more widely. Once a chest physician trusts your mucolytic or montelukast combination, the volume builds steadily without seasonal swings.
Pollution and the city market
In many north Indian cities, air quality drops sharply from late October to January. Clinics fill with patients complaining of cough, throat irritation, breathlessness and worsening asthma. Even people without any chronic condition develop persistent coughs. Demand for antihistamines, mucolytics, bronchodilators, nasal sprays and steam inhalation products rises well above normal.
If your territory includes a city affected by winter smog, plan for this. Build stock early, increase visits to chest physicians and general physicians in October, and make sure chemists in residential areas are well supplied. The pollution season can be the biggest sales period of your year if you are prepared for it.
Nebulisation at home
Home nebulisers have become common, especially for children with recurrent wheezing and older patients with COPD. Doctors prescribe respules of bronchodilators and steroids for use at home. Chemists in areas with many young families or elderly residents sell a steady number of respules.
If your company offers respules, make sure they come from a reliable manufacturer, are packed properly and carry clear instructions. Educate chemists on storage and the correct way to open and use a respule. These small details help families use the product correctly and keep coming back to your brand.
Over-the-counter sales and the chemist's role
A large share of cough and cold products, lozenges and saline nasal drops is sold without a prescription. Customers ask the chemist for "something for cough" and buy whatever the chemist recommends. In these cases, the chemist effectively becomes the prescriber.
Build relationships with chemists by keeping them reliably stocked, explaining your products clearly, and offering fair schemes during the peak season. At the same time, encourage responsible selling: chemists should know which products are suitable for children and which need a doctor's prescription. A chemist who trusts your products and understands them will recommend them dozens of times a day in winter.
Respecting the rules on cough and cold combinations
Respiratory is one of the categories where regulation has changed most in recent years. Several fixed-dose combinations used in cough and cold products have been prohibited by the government, and there have been strict actions on the quality of cough syrups, especially those meant for export and for children.
For a distributor, this means two things. First, check every combination on your product list against the current list of prohibited combinations. Ask the company to confirm in writing that each product is approved and permitted for sale. Second, take syrup quality seriously. Ask where syrups are manufactured, whether the plant follows GMP and whether raw materials are tested. A reputable company will not hesitate to answer.
Doctors are aware of these changes too. A distributor who can say clearly "every product in our list is approved, and here is the information" earns more trust than one who avoids the topic.
Licences and setup
- A wholesale drug licence from your state drug control department, commonly issued in Forms 20B and 21B
- GST registration
- Premises meeting your state's minimum requirements, with a qualified or experienced person as required
- A cool, dry storage area for syrups, suspensions and tablets
Some products, such as certain respules or reconstituted suspensions, have specific storage instructions. Follow the label for each product. Dry syrups should be kept dry until they are mixed; once reconstituted, they have a short use period that patients need to know about.
Investment and working capital
A respiratory range is moderately large and includes bulky items such as syrups, so the opening order is often a little higher than for compact ranges. Many companies ask for a first order roughly between ₹75,000 and ₹2.5 lakh, depending on the number of products and the size of your territory.
Plan for:
- Storage space for syrup cartons, which take up more room than tablets
- Freight, which is higher for liquids
- Working capital to carry 30 to 60 days of chemist credit
- Extra stock before winter, when demand rises sharply
The winter build-up is the part new distributors most often get wrong. You need to buy extra stock in October and November, before chemists start paying for it. Keep money aside for that.
Margins in respiratory products
Basic antihistamines and common cough syrups are competitive, so margins are moderate, but volumes are high in season. Montelukast combinations, mucolytics like acebrophylline, nasal sprays and specialised paediatric suspensions often leave better margins. Chronic therapy products also bring repeat business, which improves your effective margin over time because you spend less effort per sale.
When comparing companies, look at the franchise rate, MRP, free goods schemes and freight terms together, and test a few products against brands already selling in your area.
Quality checks that matter in respiratory
- Syrup quality. Taste, consistency and stability matter a great deal, especially for children. Try samples yourself. A bitter syrup will not be finished, and parents will complain.
- Suspension behaviour. Suspensions should re-disperse easily when shaken and should not cake at the bottom. Dry syrups should mix smoothly with water.
- Manufacturing and testing. Ask where syrups and suspensions are made, which certifications the plant holds and how raw materials are tested.
- Packaging. Bottles should seal properly and include a measuring cup or dropper where needed. Labels should show dosing clearly.
- Approvals. Every product and combination must be approved and permitted for sale.
Choosing a company
Look at the balance of acute and chronic products
A range made only of cough syrups will be busy for three months and quiet for nine. Look for a mix that includes montelukast combinations, mucolytics, nasal sprays and controller products as well.
Check paediatric coverage
Paediatricians are a major channel. Ask how many paediatric syrups, suspensions and drops the company offers, and test their taste and packaging.
Ask about winter supply
Many companies run short of fast-moving syrups in December and January. Ask how they plan for the peak and whether they can commit to supply.
Confirm standard terms
Territory and monopoly, minimum order, promotional material, samples, dispatch time, freight, return policy and shelf life on arrival. Get everything in writing.
Speak to existing partners
Ask partners in other districts how the company performed last winter. Their answer will tell you more than any brochure.
A respiratory sales plan through the year
Before winter (September to October)
Visit chest physicians, paediatricians and general physicians with your core list. Introduce montelukast combinations, mucolytics and two or three cough syrups. Build stock at chemists near prescribing doctors. Place your winter order early.
Winter peak (November to February)
Keep chemists stocked without fail. Visit more often. Watch which products move fastest and reorder quickly. Pollution and cold weather push demand for cough syrups, antihistamines, mucolytics and nebulisation products.
Spring (March to April)
Pollen allergies rise. Antihistamines, montelukast combinations and nasal sprays lead. ENT specialists become important.
Summer (May to June)
A quieter period for acute products. Focus on chronic patients: asthma, COPD and allergic rhinitis. Use the time to expand your doctor list.
Monsoon (July to September)
Viral infections, damp homes and mould bring a second rise in coughs, colds and allergies, particularly in children. Paediatric syrups and suspensions pick up.
Working with hospitals and nursing homes
Hospitals use respiratory products in large quantities: nebulisation solutions, injectable bronchodilators, antibiotics and mucolytics. Nursing homes with paediatric wards are especially active in winter and the monsoon. If your company offers hospital-grade products such as respules, approach nursing homes with your documents ready and a clear rate list. Remember that hospitals often take longer to pay, so price your products with that in mind.
Training your team
Representatives selling respiratory products should understand the difference between dry and wet cough, the role of antihistamines versus mucolytics, why montelukast combinations are used, and how inhalation therapy works. They should be able to explain dosing for children clearly and know which products are suitable for which age groups.
Equally important, they should know the regulatory position. A representative who promotes a combination that is no longer permitted puts your business at risk. Go through the approved product list with your team regularly.
Keeping records that help you plan
Respiratory demand follows the seasons closely, so records from one year are valuable for the next. Track monthly sales of each product, note when demand starts rising before winter and spring, and record which products ran out. Next year, you will be able to order earlier and in the right quantities. Track chemist credit closely in peak months, because high volumes can hide growing unpaid balances.
Handling complaints and returns
In a category with so many syrups and suspensions, occasional complaints are inevitable: a bottle that leaked in transit, a suspension that caked, a cap that was hard to open, a carton damaged by damp during the monsoon. How you handle these moments shapes how doctors and chemists see you.
Respond quickly. Replace damaged stock without argument where the company's policy allows, report quality complaints to the company with batch numbers and photographs, and follow up until you get an answer. Let the doctor or chemist know what happened. Most people accept that problems occur; what they do not forgive is being ignored. A distributor known for fixing problems fast keeps accounts even when competitors offer bigger schemes.
Mistakes to avoid
- Building only on cough syrups. Add chronic therapy products for year-round stability.
- Ordering late for winter. Stock up in October, not December.
- Ignoring regulatory changes. Check every combination against the current prohibited list.
- Neglecting paediatric quality. Taste and dosing accuracy matter enormously for children's products.
- Letting credit run out of control in peak season. Review outstanding payments weekly.
- No written agreement. Territory, monopoly, rates and returns should all be documented.
How respiratory fits with other ranges
Respiratory products sit comfortably beside a paediatric range, a general range or an ENT range. Antibiotic suspensions, paracetamol syrups and probiotics are often prescribed together with cough and allergy medicines, so a distributor covering these can capture the full prescription. Many distributors find that respiratory is their biggest earner in winter, while gastro or general products carry the business in summer.
About Holy Evolution Pharma
Holy Evolution Pharma is a verified Diamond member of Apromart, based in Chandigarh and has been in the pharma business since 2020. If you are exploring a respiratory franchise, you can look through the company's product catalog and services on its Apromart company page, or send an enquiry to discuss territory, product list and terms directly with the company. As with any partner, confirm the details covered in this guide — approvals, rates, monopoly and dispatch terms — in writing before you place your first order.
Frequently asked questions
What is a respiratory PCD pharma franchise?
It is a franchise where a pharma company gives you rights to promote and sell its respiratory products — cough syrups, anti-allergy medicines, mucolytics, bronchodilators, nasal sprays and paediatric suspensions — in a fixed territory.
Which respiratory products sell the most?
Montelukast with levocetirizine, cough syrups, mucolytics such as acebrophylline and ambroxol, antihistamines and paediatric syrups and suspensions are among the highest-volume products.
Is respiratory a seasonal business?
Acute products peak in winter and the monsoon, with a spring rise in allergies. Chronic therapy for asthma, COPD and allergic rhinitis keeps demand steady through the year.
Do I need to worry about banned cough combinations?
Yes. Several cough and cold combinations have been prohibited. Ask the company to confirm that every product on your list is approved and permitted, and recheck when rules change.
How much investment does a respiratory franchise need?
Many companies ask for a first order of roughly ₹75,000 to ₹2.5 lakh. Plan for extra stock before winter, storage for syrups and working capital for chemist credit.
Which doctors should I target first?
Paediatricians and general physicians bring the most volume. Chest physicians bring valuable chronic prescriptions, and ENT specialists are important for allergy products.
What licences are required?
A wholesale drug licence, commonly in Forms 20B and 21B, and GST registration. Check your state's requirements for premises and staff.
How do I check syrup and suspension quality?
Taste the samples, check how suspensions re-disperse when shaken, look at packaging and dosing aids, and ask where the products are manufactured and how raw materials are tested.
Final thoughts
A respiratory franchise rewards planning. The demand is enormous and predictable, but it arrives in waves. Distributors who stock early, keep chemists supplied through the peak, build a base of chronic patients and stay on the right side of the rules end up with a business that is busy in winter and steady the rest of the year. Choose a company with reliable syrup quality, clear approvals and a proven record of supply during peak months, and build from there.
